外周血管疾病患者神经病变筛查有助于识别截肢、血运重建和死亡风险增加者
单中心招募86例因外周动脉疾病(PAD)转诊至血管外科门诊的患者,排除已有神经病变或截肢史者,采用密歇根神经病变筛查量表(MNSI)筛查。20%患者存在神经病变,MNSI异常与复合结局(截肢、血运重建或死亡)风险增加显著相关(HR=3.19,P 0.0005)。
要点
- 因PAD就诊于血管专科的患者中20%存在未诊断的神经病变。
- MNSI异常与截肢、血运重建或死亡复合结局风险增加相关(HR=3.19,P 0.0005)。
- 作者认为扩大血管外科门诊神经病变筛查可能有助于识别高危患者。
核心结论
- 相当比例因PAD就诊于血管专科的患者存在未诊断的神经病变。
- PAD合并神经病变患者截肢、血运重建和死亡风险增加。
- 作者认为扩大血管外科门诊神经病变筛查可能有助于识别更高风险患者。
研究设计与样本
- 单中心招募因PAD转诊至血管外科门诊的患者。
- 排除标准为有记录的神经病变史或既往下肢截肢。
- 采用密歇根神经病变筛查量表(MNSI)筛查,评分>2.5视为异常,>4视为神经病变阳性。
- 采用时间至事件分析对肢体特异性结局(截肢、血运重建)及包含死亡的复合结局建模。
- 共纳入86例患者,平均年龄67±10.2岁,30%为女性,24%为黑人。
主要发现
- 平均踝肱指数为0.74±0.3。
- 初始评估时PAD症状为跛行者占52%,CLTI者占38%。
- 队列中20%存在神经病变,糖尿病患者比例显著更高(34% vs 3%;P=0.0009)。
- CLTI患者神经病变较跛行患者更常见(36% vs 9%;P=0.011)。
- 40例患者(47%)达到截肢、血运重建或死亡的复合结局,中位事件时间为16个月;MNSI检查异常与复合结局风险增加显著相关(HR=3.19;P 0.0005)。
关键数值与推荐
- MNSI评分>2.5视为异常,>4视为外周神经病变阳性。
临床怎么用
- 作者认为扩大血管外科门诊就诊时的神经病变筛查可能有助于识别更高风险患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Peripheral neuropathy is associated with amputation risk among patients with diabetes mellitus and chronic limb-threatening ischemia (CLTI). Detection of peripheral neuropathy may help identify those who are at an increased risk, but the predictive ability of the screening tool used in patients with peripheral arterial disease (PAD) needs to be more clearly defined. METHODS: Patients referred to vascular surgery clinic for PAD were recruited from a single center. Exclusion criteria were a documented history of neuropathy or prior lower limb amputation. Screening utilized the Michigan Neuropathy Screening Instrument (MNSI). Scores >2.5 were considered abnormal and scores >4 were considered positive for peripheral neuropathy. Limb-specific outcomes of amputation and revascularization as well as a composite outcome including death were modeled using time to event analysis. RESULTS: 86 patients were recruited. Mean age was 67 ± 10.2 years, 30% were women, 24% were black. Mean ankle-brachial index was 0.74 ± 0.3. PAD symptoms at initial evaluation were claudication in 52% of patients and CLTI in 38% of patients. Neuropathy was present in 20% of the cohort with a significantly higher proportion in diabetics (34% vs. 3%; P = 0.0009). Neuropathy was more common in patients with CLTI compared to claudicants (36% vs. 9%; P = 0.011). Forty patients (47%) reached the composite outcome of amputation, revascularization, or death with a median time to event of 16 months. Abnormal MNSI examination was significantly associated with the increased risk of the composite outcome (hazard ratio = 3.19; P 0.0005). CONCLUSIONS: A significant proportion of patients presenting to vascular specialists for PAD have undiagnosed neuropathy. Patients with PAD and neuropathy have an increased risk of amputation, revascularization, and death. Expanding neuropathy screening in vascular surgery clinic visits may help to identify patients at higher risk.
引用
- Hunter L, Wiley A, Mckinney G, et al. Neuropathy Screening for Patients with Peripheral Vascular Disease Helps to Identify Those at an Increased Risk of Amputation, Revascularization, and Death. Ann Vasc Surg. 2023. PMID: 38128695. doi:10.1016/j.avsg.2023.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。